Jump to navigation Jump to search
Etifoxin Wiki Str.png
Clinical data
ATC code
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Molar mass300.782 g/mol

WikiDoc Resources for Etifoxine


Most recent articles on Etifoxine

Most cited articles on Etifoxine

Review articles on Etifoxine

Articles on Etifoxine in N Eng J Med, Lancet, BMJ


Powerpoint slides on Etifoxine

Images of Etifoxine

Photos of Etifoxine

Podcasts & MP3s on Etifoxine

Videos on Etifoxine

Evidence Based Medicine

Cochrane Collaboration on Etifoxine

Bandolier on Etifoxine

TRIP on Etifoxine

Clinical Trials

Ongoing Trials on Etifoxine at Clinical

Trial results on Etifoxine

Clinical Trials on Etifoxine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Etifoxine

NICE Guidance on Etifoxine


FDA on Etifoxine

CDC on Etifoxine


Books on Etifoxine


Etifoxine in the news

Be alerted to news on Etifoxine

News trends on Etifoxine


Blogs on Etifoxine


Definitions of Etifoxine

Patient Resources / Community

Patient resources on Etifoxine

Discussion groups on Etifoxine

Patient Handouts on Etifoxine

Directions to Hospitals Treating Etifoxine

Risk calculators and risk factors for Etifoxine

Healthcare Provider Resources

Symptoms of Etifoxine

Causes & Risk Factors for Etifoxine

Diagnostic studies for Etifoxine

Treatment of Etifoxine

Continuing Medical Education (CME)

CME Programs on Etifoxine


Etifoxine en Espanol

Etifoxine en Francais


Etifoxine in the Marketplace

Patents on Etifoxine

Experimental / Informatics

List of terms related to Etifoxine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Etifoxine (or etafenoxine) is an anxiolytic and anticonvulsant drug.[1] It has similar effects to benzodiazepine drugs, but is structurally distinct and so is classed as a nonbenzodiazepine anxiolytic.[2] It is more effective than lorazepam as an anxiolytic, but has less side effects.[3]

Unlike benzodiazepines, etifoxine appears to produce its anxiolytic effects by binding to β2 and β3 subunits of the GABAA receptor complex, and so is acting at a different target site to benzodiazepines, although the physiological effect that is produced is similar to that of benzodiazepines.[4] This difference in binding means that etifoxine can be used alongside benzodiazepines to potentiate their effects without competing for binding sites,[5] however it also means that the effects of etifoxine are not reversed by the benzodiazepine antagonist flumazenil.[6]



  1. Kruse HJ, Kuch H. Etifoxine: evaluation of its anticonvulsant profile in mice in comparison with sodium valproate, phenytoin and clobazam. Arzneimittelforschung. 1985;35(1):133-5.
  2. Schlichter R, Rybalchenko V, Poisbeau P, Verleye M, Gillardin J. Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine. Neuropharmacology. 2000 Jul 10;39(9):1523-35.
  3. Nguyen N, Fakra E, Pradel V, Jouve E, Alquier C, Le Guern ME, Micallef J, Blin O. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice. Human Psychopharmacology. 2006 Apr;21(3):139-49.
  4. Hamon A, Morel A, Hue B, Verleye M, Gillardin JM. The modulatory effects of the anxiolytic etifoxine on GABA(A) receptors are mediated by the beta subunit. Neuropharmacology. 2003 Sep;45(3):293-303.
  5. Kruse HJ, Kuch H. Potentiation of clobazam's anticonvulsant activity by etifoxine, a non-benzodiazepine tranquilizer, in mice. Comparison studies with sodium valproate. Arzneimittelforschung. 1986 Sep;36(9):1320-2.
  6. Verleye M, Schlichter R, Gillardin JM. Interactions of etifoxine with the chloride channel coupled to the GABA(A) receptor complex. Neuroreport. 1999 Oct 19;10(15):3207-10.
  • The Merck Index, 12th Edition. 3910